Epilepsy Conferences | Epilepsy Conferences 2018| Neurology Conferences | Epilepsy meetings 2018|Epilepsy Congress| Neurological disorders Conferences |Neuroscience Conferences| | Japan| Asia pacific | 2018

Theme: Progressive study and emerging therapies for improvement of Epileptic life

Epilepsy Treatment 2018

Scientific Program(2018)

Epilepsy Treatment 2018

On behalf of the Conference Series llc Ltd , It’s a Pleasure to welcome you to our official Epilepsy Treatment Conferences website of 4th World Congress on Epilepsy and Treatment November 16-17, 2018 . Epilepsy Treatment 2018 is been organized around the theme “Progressive study and emerging therapies for improvement of epileptic life”

Track 1: Epilepsy

Epilepsy is a very common Neurodegenerative disorder that affects the brain. When someone having epilepsy, it means they must have an affinity to epileptic seizures. There are different types of seizure. What happens to someone having seizure for a long time depends on which portion of their brain is affected? During some types of seizure the person may remain attentive and conscious about what’s going on around them, and with other types they may lose consciousness. They may have uncommon sensations, feelings or movements. Or they may go inflexible, fall to the floor and jerk. The main treatment for epilepsy is epileptic medicines. These are called anti-epileptic drugs or AEDs. The medicine may doesn’t cure epilepsy, but supports to stop or decrease the number of seizures.

24th International Conference on Neuroscience and Neurochemistry, May 24-26, 2018 ,Barcelona ,Spain; 23rd International Conference on Neurology and Neurosurgery ,April 23-25, 2018,Rome, Italy; 25th European Neurology Congress, August 06-08, 2018, Madrid, Spain; The 4th Congress of the European Academy of Neurology 16 - 19 June, 2018, Lisbon, Portugal; International Conference on Neurology, Psychological and Brain Disorders, 21-23 May,2018, Paris, France; 4th International Conference on Depression, Anxiety and Stress Management ,May 10-11, 2018, Frankfurt, Germany; 22nd International Conference on Neurology & Neurophysiology,April 23-25, 2018, Rome, Italy. World Summit on Heart, Stroke & Neurological Disorders , August 31-September 01, 2018 Boston, Massachusetts, USA.

Track 2: Semiology and Pathophysiology of Epilepsy

Epileptic seizures are categorized by a variety of symptoms. Their typical semiology served for a long time as the major tool to classify epilepsy syndromes. The signs and symptoms of epileptic seizures include the following spheres: sensorial sphere, consciousness, motor and autonomic spheres. Most seizures involve more than one sphere, however, some like for instance aura (sensorial sphere) or dialeptic seizures (consciousness) involve only one sphere. The predominant clinical features of a seizure determine the seizure classification. The following review gives an introduction into the semiological seizure classification. This approach enables us to better identify the epileptogenic zone of our patients and to choose the most effective medical or surgical treatment.

Pathophysiology is a union of pathology and physiology that explains the practical variations in a diseased state. This session will review the pathways for seizure occurrence, ion channel defects, the essential currency of Neuronal excitability, clinical signs, signalling, and Inflammatory and mTOR pathways.

Track 3: Fibromyalgia

Fibromyalgia is a common and complex long-lasting pain condition that causes extensive pain and sensitivity to touch that may occur body wide or migrate over the body. Signs of fibromyalgia can vary in intensity. Tiredness, sleep turbulences (sleep apnea and/or waking up unrefreshed), cognitive complications (memory problems or thinking clearly), and stiffness are the most prevalent symptoms stated. repeated nerve stimulus causes the brains of people with fibromyalgia to change. There is no treatment for fibromyalgia. Multi-disciplinary tactics for management and release of symptoms are often suggested. Segregation and feeling alone to accomplish fibromyalgia can contribute to depression.

Track-4 Seizures and Tremors

Seizures basically a Neurological disorder which may results into changes of the electrical activity inside the brain. This change may cause dramatic, visible symptoms or may not cause any symptoms. The symptoms of a severe seizure include violent shaking and a loss of control. Moreover, a mild seizure may cause for a sign of different significant medical problem, so identifying the cause is very important. Because some kind of seizures may lead to injury or be indication of an underlying medical situation.

Tremor is an involuntary& rhythmic condition which may leads to muscle contraction and relaxation involving twitching movements of all body parts i.e. hands, arms, eyes, face, head, vocal folds, trunk, and legs. Tremors occur mostly in the hands. It’s basically a neurological disorder. It includes with the disorders in the parts of the brain which control muscles movement throughout of the body. Parkinson's disease is also associated with tremor. Tremors results into the indication of hypoglycemia, along with sweating and anxiety. Tremor also caused by lack of sleep, lack of vitamins, or increased stress. Different types of tremors are as follows:

Track 5: Epilepsy in children

Epilepsy affects in all ages. But for children, a different type of issues that can affect one's childhood. Some kind of epilepsy ends after childhood. Some kinds of epilepsy are related to the conditions of childhood that terminate once a child grows up. About 70% of children who are having epilepsy in their childhood may results into termination of child’s growth. There are also different seizures, such as febrile seizures, that occur one-time during childhood, and they may not result in stable epilepsy.

Track 6: Epilepsy in Woman and Inborn

Some issues with epilepsy are specific to woman. Woman with epileptic seizures have close link between hormones and epileptic seizures. Hormones may increase the risk of seizures in woman with epilepsy. Women with epilepsy also have lower fertility rates and are more likely to have anovulatory menstrual cycles, polycystic ovaries, and sexual dysfunction. Irregular menstrual cycles, hirsutism, acne, and obesity should prompt an evaluation for reproductive dysfunction. This risk is reduced by using a single antiepileptic drug at the lowest effective dose and by providing preconceptional folic acid supplementation. Breastfeeding is generally thought to be safe for women using antiepileptic medications.

Track 7: Geriatric Epilepsy

Epilepsy is the most common severe nerve disorder in the elderly after stroke and dementia. Older patients most often have focal seizures. Diagnosis can be challenging because of several patient-related, physician-related and investigation-related factors. Treatment is complicated by the presence of physiological changes related to aging, co-morbidities and cognitive problems as well as concerns regarding drug interactions and medication adherence. Seizures can be controlled in most patients with low doses of a single anti-epileptic drug (AED). Elderly patients are more likely to respond to AEDs and at lower doses than required in younger patients.

Track 8: Nerve Disorders

The nervous system is a complex, sophisticated system that regulates and coordinates body activities. It is made up of two major divisions, Central nervous system and peripheral nervous system,Disorders of nervous system may involve Vascular disorders, such as stroke, transient ischemic attack (TIA), subarachnoid hemorrhage, subdural hemorrhage and hematoma, and extradural hemorrhage, Infections, such as meningitis, encephalitis, polio, and epidural abscess, Structural disorders, such as brain or spinal cord injury, Bell's palsy, cervical spondylitis, carpal tunnel syndrome, brain or spinal cord tumors, peripheral neuropathy, and Guillain-Barré syndrome, Functional disorders, such as headache, epilepsy, dizziness, and neuralgia, Degeneration, such as Parkinson disease, multiple sclerosis, amyotrophic lateral sclerosis (ALS), Huntington chorea, and Alzheimer disease.

Track 9: Dementia

Dementia is a group of symptoms caused by brain disorders affecting the ability of brain cells to communicate with each other and loose the memory, thinking and social abilities severely enough to interfere with daily functioning. They may lose their ability to solve problems or control their feelings. Their personalities may change. They may become disturbed or see things that are not there. Many different diseases can cause dementia, including Alzheimer's disease and stroke. Risk factors for dementia include hardening of the arteries, high blood pressure, diabetes, high cholesterol, and smoking. There is no one test to determine if someone has dementia, it cab ne diagnosed by patient medical history, changes in regular activities, behaviour and their functioning. Drugs does not show any action to cure the dementia, it can be cured by environmental changes, a planned schedule, regular exercise, and staying engaged with others.

Track 10: Parkinson’s

Parkinson's disease (PD) is a neurodegenerative and a type of movement disorder. Parkinson’s disease affects the nerve cells in the brain that produce dopamine. Parkinson’s disease symptoms include muscle inflexibility, tremors, and changes in speech and gait. This disease affects about 50 percent more men than women. Risk factors for Parkinson’s include Age, Heredity, Sex, and Exposure to toxins. People with Parkinson's also lose the nerve endings that produce norepinephrine, the main chemical messenger of the sympathetic nervous system, which controls many automatic functions of the body, such as heart rate and blood pressure. After diagnosis, treatments can help relieve symptoms, but there is no cure. Coffee and green tea may reduce the risk of Parkinson’s disease Surgery and deep brain stimulation Therapy (DBST) can help severe cases. With DBS, electrodes are surgically implanted in the brain. They send electrical pulses to stimulate the parts of the brain that control movement.

Track 11: Cognitive Disorders of Epilepsy

Cognitive Disorders are very common in epilepsy patients. Most cognitive complaints in adult patients are mental slowness, memory difficulties and attention deficits. In children, cognitive problems are more diffuse, responsible for verbal troubles, learning difficulties, poor academic outcome, behavior problems and finally unfortunate socio-professional prognosis. Timely diagnosis and treatment can help to reduce their impact on the patient's quality of life. AEDs during pregnancy may cause cognitive disorders in the child exposed to them in utero. Cognitive disorders can also present as a complication of surgery for refractory epilepsy. Special care must be taken to detect cognitive side effects associated with AEDs, which seem to be more common with classic than with new AEDs, and in those patients receiving polytherapy. Neuropsychological assessment should be routinely performed before epilepsy surgery to predict possible postsurgical cognitive deficits.

Track 12: Epileptic Syndromes

Epilepsy causes may be results into epileptic syndromes by the specific features .These features include the period of time for having seizure in any person, the types of seizure, EEG findings, etc. Epileptic syndrome identification is useful as it helps to determine the basic causes as well as what anti-seizure medication should be given. Syndromes in which causes are not clearly recognized are very difficult to match with the modern classification of epilepsy. Classification for these cases was made arbitrarily. The idiopathic (unknown cause) categorization includes the syndromes in which the general medical features or age specificity strongly point to a supposed genetic cause. Childhood epilepsy syndromes are includes (unknown cause) class in which the cause is recognized genetic, for example benign rolandic epilepsy. Clinical syndromes in which epilepsy is not the leading feature (e.g. Angelman syndrome) were classified symptomatic but it was claimed to include these within the idiopathic classification. Classification of epileptic syndromes will may change with advances in research.

Track 13: Advanced Epilepsy Diagnosis Assessment

Epilepsy can be diagnosed by the following tests:

Track 14: Fast Aid For Seizures

The first aid of response when any person is having seizure is to deliver general carefulness and comfort and keep the person safe. There are a large number of seizures. Most of the seizures end within few minutes. These are some common steps to help someone who is having any kind of seizure:

Fast Aid should be continued with the person until the seizure ends and the patient is fully awake. After it ends, help the person to sit in a safe place.
Relief the person and speak softly.
Check to see if the person is wearing or a medical armlet or other emergency information
Keep yourself and other people quiet.
Agreement to call a taxi or another person to make sure the person gets home safely.

Track 15: Prevention and Management of Nerve Disorders

The best prevention managements of nerve disorders include Excersing regularly, Quitting tobacco and alcohol consumption, Control in Diabetes and High blood pressure, Eat balanced diet rich in vitaminsB6, B12 and lots of fresh fruits, vegetables and whole grains to protect nervous system. Drink plenty of water and other fluids. This helps prevent dehydration, which can cause confusion and memory problems. Drink extra water before, during, and after exercise. Take a container of water or sports drink with you when you exercise, and try to drink at least every 15 to 20 minutes. Limit your intake of caffeinated drinks, such as coffee and colas, which increase dehydration and can affect sleep.

Track 16: Cannabis

Medical marijuana is the whole plant of marijuana used for medical purposes. Marijuana is known by many names; the most common is cannabis. “Twenty-one percent of subjects had used cannabis in the past year with the majority of active users reporting beneficial effects on seizures. Twenty-four percent of all subjects believed marijuana was an effective therapy for epilepsy.

Cannabinoids are substances in cannabis that act on cells in the body (called cannabinoid receptors) to cause some effect. Two major ingredients include:

Tetrahydrocannabinol, or THC, which causes the psychoactive effects of "getting high"

Cannabidiol, or CBD, which does not cause psychoactive effects but has shown some positive effects on certain body systems and may potentially affect seizures.

Track 17: Epilepsy Therapeutics

Epilepsy Medications are mainstays in controlling epileptic seizures. Individuals with epilepsy regularly encounter cognitive dysfunctioning and some other neurological and neurobehavioral disorders which might show a dynamic course associated with worsening seizure control.

So, novel treatments for seizures and the neurological comorbidities of epilepsy such as Gene therapy, Brain Stimulation, MicroRNA regulation, Stem Cells to the Rescue, Immunotherapy are mostly required. Our Epilepsy and Treatment meetings deal with many issues in the field of epilepsy research and novel therapeutic strategies. Surgical approaches are another measurement in treatment. What's more, the Ketogenic diet, Rehabilitation and the Seizure Altering Devices are additionally having the most extreme significance and Translational examination could be new and developing model that expects to enhance health of a patient by accelerating fundamental science revelations.

Track 18: Deep Brain Stimulation (DBS) Therapy

Deep brain stimulation (DBS) is a neurosurgical therapy involving the implantation of a medical device called a neurostimulator i.e. called as 'brain pacemaker' which helps to send electrical impulses through inserted electrodes, to exact targets in the brain nuclei for the treatment of movement and neuropsychiatric syndromes. DBS therapy select brain areas to providing therapeutic supports for treatment-resistant syndromes like Parkinson's disease, essential tremor, dystonia, chronic pain, major depression and obsessive–compulsive disorder (OCD)etc.

Track 19: Novel Therapeutic Strategies For Epilepsy

Therapeutic Strategies in Epilepsy is a current account of all available treatments and interferences in all phases of epilepsy. Chapters discuss seizure classification, epilepsies with differing ages of onset, diagnosis and differential diagnosis, management, drug treatments, and special considerations for those with concomitant complications. A guide for physicians for treating epileptic patients that can be used at the point of care, this important new work brings together an expert editorial team and leading experts to review the therapeutic agents currently available and assess their effectiveness. A valuable resource for experts and general physicians to keep in touch of the modern literature from a clinical viewpoint, thus relieving in the recognition of the disease and providing the most effective interference.

Track 20: Epilepsy Case Reports

Epilepsy is a branch of medicine which deals with certain disorders of the nervous system. There are about more than 600 epilepsy disorders. Major types of Epileptic diseases occur due to faulty genes or injuries to the spinal cord or brain. The physical symptoms of epileptic diseases include partial or complete paralysis, muscle weakness etc. The medical specialty concerned with the diagnosis and treatment of disorders of the nervous system, which includes the brain, the spinal cord, and the nerves. A neurologist is a doctor who specializes in treating diseases of the CNS, which includes the brain and spinal cord.

We are truly delighted to invite you to attend the 4th World Congress on Epilepsy and Nervous system Disorders, during Nov 16-17, 2018 at Tokyo, Japan. Epilepsy treatment 2018 will provide two days of robust discussions for the treatment of various types of Epilepsy and its effects in pregnant women, Infantile Seizures, Genetic causes, mutations and other novel therapeutic and diagnostic approaches of Epilepsy. It will also explore new ideas and concepts on a global scale.

Benefits of attending a conference

· Meet experts face to face

· Networking Opportunities

· Learning In a New Space

· Break Out of Your Comfort Zone

· New Tips & Tactics

· Greater Focus

· The Energy of Like-Minded Individuals

· Invest In Yourself

C onference Series llc Ltd provides the perfect platform for global networking and our Epilepsy Treatment 2018 conference aims to gather the Professors, Researchers, Business Delegates, and Scientists, students across the globe to provide an international forum for the dissemination of original research results, new ideas and practical development experiences.

We are truly delighted to invite you to attend the 4th World Congress on Epilepsy and Treatment, during Nov 16-17, 2018 at Toyko, Japan. Epilepsy treatment 2018 will provide two days of robust discussions for the treatment of various types of Epilepsy and its effects in pregnant women, Infantile Seizures, Genetic causes, mutations and other novel therapeutic and diagnostic approaches of Epilepsy. It will also explore new ideas and concepts on a global scale.

Epilepsy is the fourth common neurodegenerative disorder and affects people of all ages. Public perception and misunderstanding of epilepsy causes challenges often worse than the seizures.

The seizures in epilepsy can be associated with brain injury or a family tendency, but most of the time the cause is unknown.

“Seizures are caused by disturbances in the electrical activity of the brain”

Epilepsy is a very common neurodegenerative disorder that affects about 65 million people worldwide. In the United States, 1 in 26 people will develop epilepsy at few points in their lifetime. Ten out of thousand numbers of people on earth develops active seizures at once in life. In the United State 150,000 number of people lives with epilepsy in each year.1/3^rd number of people with epilepsy who live with uncontrollable seizures because no available treatment works for them. Cause of epilepsy is unknown for those ten people out of six.

Scope & Importance

Epilepsy is a non-communicable disorder of the brain that affects people of all ages. According to WHO (World Health Organization) statistics more than 50 million people are affected in the world. It is estimated that every year nearly 2.4 million people are diagnosed with epilepsy and the population with active epilepsy is between 4 to10 per 1000 people. Approximately 50 million people in the world have epilepsy, now days which is one of the common neurological diseases globally. Nearly 80% people in the world live in low- and middle-income countries with epilepsy. Approximately 70% of the people with epilepsy living in low-and middle-income countries get treatment as they need & rest of 3/4^th people, they do not get. In different parts of the world, many families with epilepsy suffer from stigma and discrimination.

WHY TO ATTEND THE CONFERENCE

Epilepsy Treatment 2018 conference brings together Speakers and attendees and decision-makers from different biotechnology and medical companies, major pharmaceutical and device companies, and researchers and innovators at the cutting-edge of epilepsy and CNS treatment advances. Also to create an agenda with highly innovative topics on epilepsy treatment, therapeutic innovation, and product development. Initiate demos, share information, come across with eminent personalities, and create novel antiepileptic line and latest diagnostic methods at this outstanding event.

Targeted audience

Epileptologists
Neurologists
Pharmacists
Research scientists
Anti- Epileptic drug Industries
Epilepsy associations & foundation
Professors and Students from Academia in the study of Epilepsy field.
Epilepsy organizations Biopharmaceutical (drug design and discovery) companies

Epilepsy Treatment 2018

Theme – “Progressive study and emerging therapies for improvement of Epileptic life”

ABOUT CONFERENCE

We welcome you to the official website of 4th World Congress on Epilepsy and Treatment going to be held in Tokyo, Japan; on Nov 16-17, 2018.

Conference Series llc Ltd provides the perfect platform for global networking and our Epilepsy Treatment 2018 conference aims to gather the Professors, Researchers, Business Delegates, and Scientists, students across the globe to provide an international forum for the dissemination of original research results, new ideas and practical development experiences.

We are truly delighted to invite you to attend the 4th World Congress on Epilepsy and Treatment, during Nov 16-17, 2018 at Tokyo, Japan. Epilepsy treatment 2018 will provide two days of robust discussions for the treatment of various types of Epilepsy and its effects in pregnant women, Infantile Seizures, Genetic causes, mutations and other novel therapeutic and diagnostic approaches of Epilepsy. It will also explore new ideas and concepts on a global scale.

Epilepsy is the fourth common neurodegenerative disorder and affects people of all ages. Public perception and misunderstanding of epilepsy causes challenges often worse than the seizures.The seizures in epilepsy can be associated with brain injury or a family tendency, but most of the time the cause is unknown..

“Seizures are caused by disturbances in the electrical activity of the brain”

For more details please Visit- http://epilepsy.neurologyconference.com/

SCOPE & IMPORTANCE

Why in Japan?

Epilepsy is one of the most common brain disorders, estimated to affect one million people and 50 thousand people are diagnosed with epilepsy annually in Japan. Japan Epilepsy Association and Japan Epilepsy Society have been working together to get over these problems over the years.

In japan every October is a special month to focus on epilepsy.

They state all the people of health care, organizations and policy makers to solve the global issues surrounding epilepsy.

To place epilepsy on a top priority in medical policy.
To establish a medical system for epilepsy and assure that people with epilepsy have access to modern and proper medical and health care.
To promote social integration and eliminate discrimination against epilepsy in all spheres of life, especially work, school and mobility.
To encourage educational activities for all the people to understand epilepsy and thereby reduce stigma and prejudice.
To provide experts and volunteers in the field of healthcare, education and employment with appropriate training about epilepsy.
To introduce appropriate legislation to protect the rights of all the people with epilepsy.

Conference Highlights

WHY TO ATTEND THE CONFERENCE

A Unique Opportunity for Advertisers and Sponsors at this International event:

http://epilepsy.neurologyconference.com/sponsors.php

Major Epilepsy Associations Around The Globe:

Indonesian Neurology Association
European Academy of Neurology
Epilepsy Therapy Project (ETP)
American Neurological Association (ANA)
American Academy of Neurology
Epilepsy Association For Central Florida
American Board of Psychiatry and Neurology (ABPN)
American Academy of Neurology (AAN)
American Epilepsy Society
National Institute of Neurological Disorders and Stroke
Neurological Society of India
Indian Academy of Neurology

Target Audience:

Epileptologists, Neurologists, Pharmacists, Research scientists, Anti- Epileptic drug Industries, Epilepsy associations & foundations, Professors and Students from Academia in the study of Epilepsy field, Epilepsy organizations Biopharmaceutical (drug design and discovery) companies.

Industry 20%

Academia 50%

Clinicians 20%

Others 10%

Top Universities In Indonesia Associated With Epilepsy:

Gadjah Mada University

University of Indonesia

Padjadjaran University

Diponegoro University

Brawijaya University

Universitas Pendidikan Indonesia

Trisakti University

Muhammadiyah University of Malang

University of Surabaya

Semarang University

Top Universities Associated With Epilepsy In The Globe:

University of Florida

Yale University

Duke University

University of Arizona

Columbia University

Harvard University

University of California-san franscisco

Stanford University

Johns Hopkins University

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	November 16-17, 2018
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed	Day 1	Day 2
Poster Opportunity Closed	Click Here to View